153 related articles for article (PubMed ID: 37876796)
1. Targeting metabolic fluxes reverts metastatic transitions in ovarian cancer.
Arora G; Banerjee M; Langthasa J; Bhat R; Chatterjee S
iScience; 2023 Nov; 26(11):108081. PubMed ID: 37876796
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
3. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
[TBL] [Abstract][Full Text] [Related]
4. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
[TBL] [Abstract][Full Text] [Related]
5. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.
Gunay G; Kirit HA; Kamatar A; Baghdasaryan O; Hamsici S; Acar H
Gynecol Oncol; 2020 Nov; 159(2):563-572. PubMed ID: 32958270
[TBL] [Abstract][Full Text] [Related]
6. The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone.
Ritch SJ; Noman ASM; Goyeneche AA; Telleria CM
Cancer Cell Int; 2022 Dec; 22(1):397. PubMed ID: 36494669
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.
Zhang Q; Yu S; Lam MMT; Poon TCW; Sun L; Jiao Y; Wong AST; Lee LTO
J Exp Clin Cancer Res; 2019 Mar; 38(1):116. PubMed ID: 30845964
[TBL] [Abstract][Full Text] [Related]
8. The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice.
Goyeneche A; Lisio MA; Fu L; Srinivasan R; Valdez Capuccino J; Gao ZH; Telleria C
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32188032
[TBL] [Abstract][Full Text] [Related]
9. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
10. OVCAR-3 spheroid-derived cells display distinct metabolic profiles.
Vermeersch KA; Wang L; Mezencev R; McDonald JF; Styczynski MP
PLoS One; 2015; 10(2):e0118262. PubMed ID: 25688563
[TBL] [Abstract][Full Text] [Related]
11. Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
Mukherjee A; Chiang CY; Daifotis HA; Nieman KM; Fahrmann JF; Lastra RR; Romero IL; Fiehn O; Lengyel E
Cancer Res; 2020 Apr; 80(8):1748-1761. PubMed ID: 32054768
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting ULK1 kinase decreases autophagy and cell viability in high-grade serous ovarian cancer spheroids.
Singha B; Laski J; Ramos Valdés Y; Liu E; DiMattia GE; Shepherd TG
Am J Cancer Res; 2020; 10(5):1384-1399. PubMed ID: 32509386
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer.
Sestito R; Tocci P; Roman C; Di Castro V; Bagnato A
J Exp Clin Cancer Res; 2022 Apr; 41(1):157. PubMed ID: 35477522
[TBL] [Abstract][Full Text] [Related]
14. Comparative Proteomics of Ovarian Cancer Aggregate Formation Reveals an Increased Expression of Calcium-activated Chloride Channel Regulator 1 (CLCA1).
Musrap N; Tuccitto A; Karagiannis GS; Saraon P; Batruch I; Diamandis EP
J Biol Chem; 2015 Jul; 290(28):17218-27. PubMed ID: 26004777
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
[TBL] [Abstract][Full Text] [Related]
16. Analysis of ovarian cancer cell secretome during epithelial to mesenchymal transition reveals a protein signature associated with advanced stages of ovarian tumors.
Lanfredi GP; Thomé CH; Ferreira GA; Silvestrini VC; Masson AP; Vargas AP; Grassi ML; Poersch A; Candido Dos Reis FJ; Faça VM
Biochim Biophys Acta Proteins Proteom; 2021 Jun; 1869(6):140623. PubMed ID: 33607274
[TBL] [Abstract][Full Text] [Related]
17. Follicle-Stimulating Hormone Is an Autocrine Regulator of the Ovarian Cancer Metastatic Niche Through Notch Signaling.
Gera S; Kumar S S; Swamy SN; Bhagat R; Vadaparty A; Gawari R; Bhat R; Dighe RR
J Endocr Soc; 2019 Feb; 3(2):340-357. PubMed ID: 30680340
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of cancer and mesothelial cells reveals an increase in Mucin 5AC during ovarian cancer and peritoneal interaction.
Musrap N; Karagiannis GS; Saraon P; Batruch I; Smith C; Diamandis EP
J Proteomics; 2014 May; 103():204-15. PubMed ID: 24726482
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells.
Ween MP; Lokman NA; Hoffmann P; Rodgers RJ; Ricciardelli C; Oehler MK
Int J Cancer; 2011 Apr; 128(7):1570-84. PubMed ID: 20521251
[TBL] [Abstract][Full Text] [Related]
20. A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer.
Cheon DJ; Tong Y; Sim MS; Dering J; Berel D; Cui X; Lester J; Beach JA; Tighiouart M; Walts AE; Karlan BY; Orsulic S
Clin Cancer Res; 2014 Feb; 20(3):711-23. PubMed ID: 24218511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
